Keeping Current CME

Keeping Current CME

By MedscapeMedicine Health & Fitness

Download on the App Store

Download on the App Store

Get it on Google Play

Keeping Current CME episodes

December 08, 2023 Novel Biologic Therapies for Spondyloarthritis: The Year in Review
Are you up to date on latest data on biologics in spondyloarthritis and the recent EULAR treatment recommendation updates? Join us to find out more!

Credit available for this activity expires: 12/5/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998991?ecd=bdc_podcast_libsyn_mscpedu
36 min
December 06, 2023 Relapsed/Refractory Chronic Lymphocytic Leukemia: The Evolving Role of BTK Inhibitors
Did you know that the National Comprehensive Cancer Network (NCCN) guidelines now include an investigational noncovalent BTK inhibitor for the treatment of relapsed/refractory CLL? Credit available for this activity expires: 12/05/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998747?ecd=bdc_podcast_libsyn_mscpedu
29 min
December 05, 2023 Personalizing Risk Assessment to Enhance Primary Cardiovascular Prevention: From Methods to Interpretation
Join our experts to hear about imaging strategies to determine cardiovascular (CV) risk and optimum preventive strategies. Credit available for this activity expires: 12/5/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998954?ecd=bdc_podcast_libsyn_mscpedu
35 min
December 04, 2023 Nonalcoholic Steatohepatitis: Mission Possible!
Learn to recognize, diagnose, and manage nonalcoholic steatohepatitis (NASH) and metabolic dysfunction-associated steatohepatitis (MASH). Credit available for this activity expires: 12/4/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998939?ecd=bdc_podcast_libsyn_mscpedu
32 min
December 01, 2023 Meeting of the Minds: Addressing the Gray Zone of Immunotherapy for Advanced Non-Small Cell Lung Cancer
View the experts discuss the ins and outs of immunotherapy for advanced non-small cell lung cancer (NSCLC) in the real world. Credit available for this activity expires: 11/30/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998874?ecd=bdc_podcast_libsyn_mscpedu
41 min
November 30, 2023 ROS1-Positive Advanced NSCLC: Sharing Best Practice From the Clinic to Maximize Patient Outcomes
How confident are you in managing patients your patients on ROS1 inhibitor therapy?

Credit available for this activity expires: 11/30/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998606?ecd=bdc_podcast_libsyn_mscpedu
32 min
November 28, 2023 What Does It All Mean for Your Practice? Closing Remarks From the Conference Chairs
Drs Nelson and Taylor discuss the key takeaways from all the presentations in the Women's Health Master Class.

Credit available for this activity expires: 11/28/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998784?ecd=bdc_podcast_libsyn_mscpedu
28 min
November 28, 2023 Managing the Borderline-Risk Patient With Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: Shedding Light on the Role of Surgeon, Radiologist, and Oncologist
Do you consult with the multidisciplinary team (MDT) when making treatment decisions for patients with hormone receptor (HR)-positive/HER2-negative early breast cancer (EBC)?

Credit available for this activity expires: 11/21/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998529?ecd=bdc_podcast_libsyn_mscpedu
29 min
November 28, 2023 Exploring New Strategies for the Management of Nonalcoholic Steatohepatitis: NOT a Trivial Pursuit
How do your treatment decisions compare with the experts?

Credit available for this activity expires: 11/28/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998763?ecd=bdc_podcast_libsyn_mscpedu
1 hr 2 min
November 17, 2023 Navigating Between Endocrine Therapy, Chemotherapy, and CDK 4/6 Inhibitors for High-Risk HR+/HER2- Early Breast Cancer: The Great Debate
What strategies are you using to individualize treatment of HR+/HER2- early breast cancer?

Credit available for this activity expires: 11/17/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998210?ecd=bdc_podcast_libsyn_mscpedu
33 min

About Keeping Current CME

From the publisher's feed

Hear from experts as they discuss timely clinical topics as well as relevant and actionable strategies for practice improvement. This podcast is available for CME credit.

More shows like Keeping Current CME